Evidence map›Paper›PMID 30062215›Full record

ReviewJACC. Basic to translational science2018

3D Printing is a Transformative Technology in Congenital Heart Disease.

Shafkat Anwar, Gautam K Singh, Jacob Miller, Monica Sharma, Peter Manning, Joseph J Billadello, Pirooz Eghtesady, Pamela K Woodard

Registry-linked trialAbstract readReview
In one paragraph

Review in JACC. Basic to translational science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05852106 (The Effect of 3D Modeling on Family Quality of Life, Surgical Success and Patient Outcomes in Congenital Heart Diseases), which is not on this map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05852106 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Effect of 3D Modeling on Family Quality of Life, Surgical Success and Patient Outcomes in Congenital Heart Diseases: A Randomized Controlled Trial Protocol

TypeinterventionalSponsorYeditepe UniversityRan2023 to 2024Enrolled30ConditionsCongenital Heart DiseaseArmsSurgical Simulation with 3D Heart Model and Parental Education with "Congenital Heart Disease Parent Education Booklet" and tailored 3D Heart Modeling
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Patient-specific 3DFrontiers in cardiovascular medicine · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shafkat AnwarDivision of Cardiology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Gautam K SinghDivision of Cardiology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Jacob MillerDivision of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Monica SharmaDivision of Cardiology, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Peter ManningDivision of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Joseph J BilladelloDivision of Cardiovascular Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Pirooz EghtesadyDivision of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
Pamela K WoodardMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child. To continue the gains made over the past 80 years, transformative changes with broad impact are needed in management of congenital heart disease. Three-dimensional printing is an emerging technology that is fundamentally affecting patient care, research, trainee education, and interactions among medical teams, patients, and caregivers. This paper first reviews key clinical cases where the technology has affected patient care. It then discusses 3-dimensional printing in trainee education. Thereafter, the role of this technology in communication with multidisciplinary teams, patients, and caregivers is described. Finally, the paper reviews translational technologies on the horizon that promise to take this nascent field even further.

Indexed as

3D printing3D, three-dimensionalACHD, adults with congenital heart diseaseAPC, aortopulmonary collateralsASD, atrial septal defectcardiac imagingcardiothoracic surgeryCHD, congenital heart diseasecongenital heart diseaseCT, computed tomographyDORV, double outlet right ventricleMAPCAs, multiple aortopulmonary collateralsMRI, magnetic resonance imagingOR, operating roomsimulationVSD, ventricular septal defect

Identifiers

PMID30062215
PMCPMC6059001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.